9th Annual Biomarkers Congress
Inaugural Oligonucleotide-Based Therapeutics Oct(17-18)
World Trade Center
200 Seaport Boulevard
Boston, MA
http://www.discoveryontarget.com/07ndl.asp
Inaugural Oligonucleotide-Based Therapeutics 
Cambridge Healthtech Institute

Schedule of Presentations:

Wednesday, October 17, 2007
07:30:00 Registration Opens (07:30-14:10)
14:10:00 RNAi’s IN PRECLINICAL AND CLINICAL DEVELOPMENT (14:10-18:15) John J. Rossi, Akshay Vaishnaw, David Dorris, Xiaodong Yang, Richard D Gill, Nathan . R.F Beeley
14:10:00 RNAi’s IN PRECLINICAL AND CLINICAL DEVELOPMENT: Chairperson’s Remarks (14:10-14:15) Akshay Vaishnaw
14:15:00 RNAi’s IN PRECLINICAL AND CLINICAL DEVELOPMENT: Development of Antiviral siRNAs for Pandemic Influenza (14:15-14:45) Steven Quay
14:45:00 RNAi’s IN PRECLINICAL AND CLINICAL DEVELOPMENT: Progress and Challenges of Using RNAi for the Treatment of HIV Infection (14:45-15:15) John J. Rossi
15:15:00 RNAi’s IN PRECLINICAL AND CLINICAL DEVELOPMENT: Development of Bevasiranib (15:15-15:45) Nathan . R.F Beeley
15:45:00 RNAi’s IN PRECLINICAL AND CLINICAL DEVELOPMENT: The DNAi Company PNT2258 - To the Clinic or Bust! (15:45-16:15) Richard D Gill
16:15:00 RNAi’s IN PRECLINICAL AND CLINICAL DEVELOPMENT: Networking Refreshment Break in the Exhibit Hall (16:15-16:50)
16:50:00 RNAi’s IN PRECLINICAL AND CLINICAL DEVELOPMENT: Technology Watch The Quest for Improving siRNA Performance (16:50-17:15) David Dorris
17:15:00 RNAi’s IN PRECLINICAL AND CLINICAL DEVELOPMENT: RNAi Nanoplex™ Technology for Systemic Delivery of siRNA Therapeutics in Oncology (17:15-17:45) Xiaodong Yang
17:45:00 Panel Discussion: Is the Drug Development Paradigm the Same for siRNAs and RNAi’s as compared to Other Drugs - What is the Same and What is Different? (17:45-18:15) Panel Discussion Xiaodong Yang, Nathan . R.F Beeley, Richard D Gill
18:15:00 End of Conference Day
Thursday, October 18, 2007
07:30:00 Registration & Morning Coffee (07:30-08:35)
08:35:00 ANTI-SENSE THERAPEUTICS IN CLINICAL DEVELOPMENT: LESSONS LEARNED (08:35-12:25) Levon M Khachigian, Arthur Levin, Mark Parry-Billings, Brenda F. Baker
08:35:00 ANTI-SENSE THERAPEUTICS IN CLINICAL DEVELOPMENT; LESSONS LEARNED: Chairperson’s Remarks (08:35-08:40) Arthur Levin
08:40:00 ANTI-SENSE THERAPEUTICS IN CLINICAL DEVELOPMENT; LESSONS LEARNED: Lessons Learned with First Generation Oligonucleotides (08:40-09:10) Arthur Levin
09:10:00 ANTI-SENSE THERAPEUTICS IN CLINICAL DEVELOPMENT; LESSONS LEARNED: Progress on Second Generation Antisense Oligonucleotides (09:10-09:40) Brenda F. Baker
09:40:00 ANTI-SENSE THERAPEUTICS IN CLINICAL DEVELOPMENT; LESSONS LEARNED: TPI ASM8 for the Treatment of Asthma (09:40-10:10) Mark Parry-Billings
10:10:00 ANTI-SENSE THERAPEUTICS IN CLINICAL DEVELOPMENT; LESSONS LEARNED: Networking Coffee Break in the Exhibit Hall (10:10-10:55)
10:55:00 ANTI-SENSE THERAPEUTICS IN CLINICAL DEVELOPMENT; LESSONS LEARNED: Therapeutic Possibilities of Catalytic DNA (10:55-11:55) Levon M Khachigian
11:55:00 Interactive Panel Discussion: This is Your Chance! Interactive Panel Discussion with Questions from the Floor Regarding Lessons Learned. (11:55-12:25) Discussion Levon M Khachigian, Brenda F. Baker, Mark Parry-Billings, Arthur Levin
12:25:00 Luncheon Workshop or Lunch on Your Own (12:25-12:55)
12:55:00 Session Break (12:55-13:55)
13:55:00 Update on Aptamers and Immunostimulatory Oligonucleotides in Clinical Development: Chairperson’s Remarks (13:55-14:00) Page Bouchard
13:55:00 Update on Aptamers and Immunostimulatory Oligonucleotides in Clinical Development (13:55-15:00) Christopher P. Rusconi, Page Bouchard, William Turner
14:00:00 Update on Aptamers and Immunostimulatory Oligonucleotides in Clinical Development: Development of the REG1 Anticoagulation System (14:00-14:30) Christopher P. Rusconi
14:30:00 Update on Aptamers and Immunostimulatory Oligonucleotides in Clinical Development: The Regulatory Development of HEPLISAV ™ (14:30-15:00) William Turner
15:00:00 Update on Aptamers and Immunostimulatory Oligonucleotides in Clinical Development: Networking Refreshment Break in the Exhibit Hall (15:00-15:40)
15:40:00 PROBLEMS/ISSUES ACROSS ALL OGN PLATFORMS: Delivery Challenges (15:40-16:10) Mark Tracy
15:40:00 PROBLEMS/ISSUES ACROSS ALL OGN PLATFORMS (15:40-17:10) Mark Tracy, Muthiah Manoharan, Renta Hutabarat
16:10:00 PROBLEMS/ISSUES ACROSS ALL OGN PLATFORMS: Metabolism, Metabolic Profiling, and Bioanalysis of Aptamer Therapeutics (16:10-16:40) Renta Hutabarat
16:40:00 PROBLEMS/ISSUES ACROSS ALL OGN PLATFORMS: The Chemistry Behind Oligonucleoitde Therapeutics (16:40-17:10) Muthiah Manoharan
17:10:00 Panel Discussion: Interactive Panel Discussion (17:10-17:40) Panel Discussion Mark Tracy, Dmitry Samarsky, Renta Hutabarat, Muthiah Manoharan, Arthur Levin
17:40:00 Close of Oligonucleotide-Based Therapeutics Conference
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.